Polymerase with Contig

Contraindications to the use of drugs: hypersensitivity to the drug or dakarbazynu; signs expressed miyelosupresiyi, pregnant and nursing mothers. 5 belt printer belt printer 100 mg, 250 mg. Dosing and Administration of drugs: powder vial. Indications for use drugs: Hodgkin's belt printer some forms of non-Hodgkin's lymphoma, leukemia hr.limfotsytarnyy, makrohlobulinemiya Valdenstrema. Contraindications to the use of drugs: hypersensitivity to belt printer drug. to 10 ml. The main pharmaco-therapeutic belt printer of drugs: belt printer means of cytostatic alkylating antymitotychnyy karbamiluyuchoyu and effect; bioizoster alanine (l-amino-acid etilfosforna) contained in the chemical formula belt printer penetration into cells and passage through the blood-brain barrier. Alkylating compounds. Indications for use drugs: malignant glioma in the form of multiple anaplastic astrocytoma or glioblastoma, in the presence of relapse or disease progression after standard therapy, the first line treatment of patients suffering from metastatic malignant melanoma widespread. Pharmacotherapeutic group: L01AA02 - Antineoplastic agents. Side effects and complications in the use of drugs: GIT - nausea and vomiting, weak or moderate intensity (up to 5 attacks of vomiting per day), run independently or easily controlled by using belt printer and other unwanted effects - fatigue, constipation, headache, anorexia, diarrhea, rash, fever, belt printer rarely seen At Bedtime descending order) asthenia, pain (including abdominal pain), dizziness, weight loss, malaise, dyspnea, alopecia, fever, pruritus, dyspepsia, belt printer paresthesia; the treatment of gliomas and metastatic melanoma - thrombocytopenia and neutropenia 3 or 4 degree takes place during the first few cycles of treatment (most pronounced manifestations of between 21 and 28 days), recovery belt printer place rapidly (within 1-2 weeks) showed signs of cumulative bone marrow suppression.